首页 | 本学科首页   官方微博 | 高级检索  
检索        

酶联免疫斑点法研究小鼠急性移植物抗宿主病模型中产生干扰素γ细胞的水平
引用本文:孟筱坚,林茂芳,牟海波,傅剑云,章荣华.酶联免疫斑点法研究小鼠急性移植物抗宿主病模型中产生干扰素γ细胞的水平[J].浙江大学学报(医学版),2006,35(4):397-402.
作者姓名:孟筱坚  林茂芳  牟海波  傅剑云  章荣华
作者单位:1. 浙江大学医学院附属第一医院骨髓移植中心,浙江,杭州,310003
2. 浙江省疾病预防与控制中心,浙江,杭州,310003
基金项目:国家自然科学基金;高等学校博士学科点专项科研项目;浙江省医药卫生科研项目
摘    要:目的:探讨异基因小鼠混合淋巴细胞反应(MLR)和急性移植物抗宿主病(aGVHD)模型中,供者针对受者细胞反应后产生干扰素-γ细胞(IFN-γ PC)的水平。方法:在近交系MHC不合的异基因小鼠脾细胞MLR和aGVHD模型中,用酶联免疫斑点法(ELISPOT)对供者针对受者细胞反应后IFN-γ PC的水平及其影响因素进行了研究。结果:在异基因小鼠脾细胞MLR后,用ELISPOT检测到IFN-γ PC显著升高,具有针对受者细胞的特异性。在异基因小鼠aGVHD模型中,重度aGVHD小鼠脾细胞与未移植的异基因受鼠脾细胞在MLR后,IFN-γ PC较中度aGVHD明显升高,无aGVHD药物预防组较预防组IFN-γ PC明显升高,并具有针对受者细胞的特异性,与aGVHD的临床评分相一致。结论:用ELISPOT可以快速而敏感地检测异基因小鼠脾细胞MLR中的同种异体反应,并和aGVHD的程度以及病程具有相关性。

关 键 词:异基因  同种异体反应  混合淋巴细胞反应  急性移植物抗宿主病  干扰素γ
文章编号:1008-9292(2006)04-0397-06
收稿时间:2005-10-17
修稿时间:2006-01-10

Evaluation of interferon-γ producing-cells using enzyme linked immunospot assay in mice model of acute graft versus host disease
MENG Xiao-jian, LIN Mao-fang, MOU Hai-bo, et al.Evaluation of interferon-γ producing-cells using enzyme linked immunospot assay in mice model of acute graft versus host disease[J].Journal of Zhejiang University(Medical Sciences),2006,35(4):397-402.
Authors:MENG Xiao-jian  LIN Mao-fang  MOU Hai-bo  
Institution:Department of Bone Marrow Transplantation, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China. mengxiaojian@hotmail.com
Abstract:OBJECTIVE: To investigate IFN-gamma producing-cells (IFN-gamma PCs) in allogeneic mixed lymphocyte reaction (MLR) and acute graft versus host disease (aGVHD) model of mice. METHODS: Enzyme linked immunospot assay (ELISPOT) was applied to study IFN-gamma PCs in MHC mismatched mice spleen cell MLR and aGVHD model of mice. RESULT: IFN-gamma PCs increased significantly in MLR after allogeneic mice spleen cell stimulation. In the experimental mice aGVHD model, IFN-gamma PCs were significantly higher in the severe aGVHD group than those in the moderate aGVHD. In the moderate aGVHD group, mice with GVHD prophylaxis regimen demonstrated significantly lower level of IFN-gamma PCs, compared with those without prophylaxis. IFN-gamma PCs were significantly correlated with the GVHD clinical scores in the group with moderate aGVHD and prophylaxis regimen. CONCLUSION: ELISPOT is a fast, sensitive and specific approach to evaluate alloresponse in allogeneic mice MLR and IFN-gamma PCs are correlated closely with the severity of aGVHD and prophylaxis regimen in the MHC-mismatched mice model.
Keywords:
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号